Design and feasibility of an Alzheimer's disease blood test study in a diverse community-based population.
Melody LiYan LiSuzanne E SchindlerDaniel YenSiobhan SutcliffeGanesh M BabulalTammie L S BenzingerEric J LenzeRandell J BatemanPublished in: Alzheimer's & dementia : the journal of the Alzheimer's Association (2023)
A diverse group of older adults was recruited to evaluate a blood amyloid test. The enrollment rate was high and the blood test was well accepted by participants. Cognitive impairment screens have moderate performance in a diverse population. Alzheimer's disease blood tests are likely to be feasible for use in real-world settings.